Beijing Science Sun Pharmaceutical Co.,Ltd.’s Net Profit Dropped 99.6% in First Quarter of 2023

Beijing Science Sun Pharmaceutical Co.,Ltd. (北京赛升药业股份有限公司) (300485.SZ) reported a net profit of 406,467 yuan in the first quarter of 2023, down 99.6% year-on-year.

Meanwhile, the company posted 132.7 million yuan in revenue, down 30.9% year-on-year.

At the end of the reporting period, it had 3.5 billion yuan in total assets and 136.7 million yuan in total liabilities, with a liability-to-asset ratio of 3.9%.